KKR Genetic Disorder L.P.'s Net Worth
$1.29 Billion
Who is KKR Genetic Disorder L.P.?
KKR Genetic Disorder L.P. has an estimated net worth of $1.29 Billion. This is based on reported shares in BridgeBio Pharma, Inc..
SEC CIK
KKR Genetic Disorder L.P.'s CIK is 0001780408
Past Insider Trading and Trends
2019 was KKR Genetic Disorder L.P.'s most active year for acquiring shares with 2 total transactions. KKR Genetic Disorder L.P.'s most active month to acquire stocks was the month of June. 2019 was KKR Genetic Disorder L.P.'s most active year for disposing of shares, totalling 3 transactions. KKR Genetic Disorder L.P.'s most active month to dispose stocks was the month of June. 2019 saw KKR Genetic Disorder L.P. paying a total of $45,000,700.00 for 36,900,661 shares, this is the most they've acquired in one year. In 2021 KKR Genetic Disorder L.P. cashed out on 3,450,000 shares for a total of $208,617,360.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $33.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.00% | -3.45M |
$60.47 | -$208,617,360.00 | 31.06M |
Feb 17
| |||
Form 4
| -6.48% | -2.39M |
$33.39 | -$79,791,749.10 | 34.51M |
May 28
| |||
Form 4
|
∞
| 36.9M |
$17.00 |
—
| 36.9M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||